Get the Stockscreener App
17.59
1.79%
0.31
After Hours:
17.20
-0.39
-2.22%
Entrada Therapeutics Inc Stock (TRDA) Forecast
The Entrada Therapeutics Inc (TRDA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $17.87, representing a +1.58% increase from the current price of $17.59. The highest analyst price target is $20.24, and the lowest is $15.49.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TRDA Price Target
Average 22.47
(+27.74% Upside)
Is Entrada Therapeutics Inc (TRDA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.90 | Neutral |
| STOCH(9,6) | 13.02 | Buy |
| STOCHRSI(14) | 11.16 | Buy |
| MACD(12,26) | -0.2699 | Sell |
| ADX(14) | 23.75 | Neutral |
| William %R | -85.19 | Buy |
| CCI(14) | -75.65 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
18.61
Sell
|
18.29
Sell
|
| MA20 |
19.27
Sell
|
18.70
Sell
|
| MA50 |
18.48
Sell
|
18.33
Sell
|
| MA100 |
17.04
Buy
|
17.47
Buy
|
| MA200 |
15.77
Buy
|
16.54
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, TRDA could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on TRDA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 41.9 indicates that TRDA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 13.02 indicates that TRDA is oversold. This indicates that TRDA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.16 indicates that TRDA is oversold. This suggests that TRDA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.75 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -75.65 indicates that TRDA is still oversold but not to an extreme extent.
Long-term TRDA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Entrada Therapeutics Inc financial reports and earnings history, Entrada Therapeutics Inc (TRDA) stock could reach $23.53 by 2030, $56.50 by 2040 and $80.47 by 2050. See the projected annual prices until 2050 of the Entrada Therapeutics Inc stock below:
- Entrada Therapeutics Inc (TRDA) is expected to reach an average price of $33.63 in 2035, with a high prediction of $34.72 and a low estimate of $30.61. This indicates an $91.21% rise from the last recorded price of $17.59.
- Entrada Therapeutics Inc (TRDA) stock is projected to chart a bullish course in 2040, with an average price target of $55.31, representing an $214.45% surge from its current level. The forecast ranges from a conservative $54.34 to a sky-high $56.50.
- Our analysts predict Entrada Therapeutics Inc (TRDA) to jump 291.24% by 2045, soaring from $64.62 to an average price of $68.82, potentially reaching $69.15. While $64.62 is the low estimate, the potential upside is significant.
- Entrada Therapeutics Inc (TRDA) stock is expected to climb by 2050, reaching an average of $79.48, a $351.87% jump from its current level. However, a wide range of estimates exists, with high and low targets of $80.47 and $75.78, respectively, highlighting the market's uncertainty.
Entrada Therapeutics Inc Stock (TRDA) Year by Year Forecast
Entrada Therapeutics Inc Stock (TRDA) Price Forecast for 2025
Entrada Therapeutics Inc Stock (TRDA) is expected to reach an average price of $22.47 in 2025, with a high prediction of $29.84 and a low estimate of $15.10. This indicates an +27.74% rise from the last recorded price of $17.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $17.91 | $15.49 | $20.24 | +1.83% |
| February, 2025 | $20.44 | $16.87 | $20.98 | +16.22% |
| March, 2025 | $24.27 | $18.83 | $24.57 | +38.00% |
| April, 2025 | $23.38 | $22.39 | $29.84 | +32.93% |
| May, 2025 | $24.65 | $17.99 | $27.22 | +40.16% |
| June, 2025 | $19.89 | $17.69 | $27.02 | +13.10% |
| July, 2025 | $20.14 | $16.84 | $21.37 | +14.51% |
| August, 2025 | $18.56 | $15.10 | $22.77 | +5.53% |
| September, 2025 | $20.96 | $15.32 | $23.13 | +19.18% |
| October, 2025 | $17.68 | $17.16 | $24.36 | +0.53% |
| November, 2025 | $17.80 | $16.74 | $20.03 | +1.21% |
| December, 2025 | $20.87 | $16.68 | $23.23 | +18.66% |
Entrada Therapeutics Inc Stock (TRDA) Price Forecast for 2026
The predicted value for Entrada Therapeutics Inc (TRDA) in 2026 is set at an average of $20.98. Estimates vary from a peak of $24.64 to a trough of $17.32, indicating an +19.29% surge from the present price of $17.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $23.26 | $17.39 | $24.64 | +32.25% |
| February, 2026 | $22.68 | $19.79 | $23.76 | +28.96% |
| March, 2026 | $21.75 | $20.71 | $23.95 | +23.67% |
| April, 2026 | $21.28 | $19.31 | $23.20 | +20.99% |
| May, 2026 | $22.51 | $19.14 | $23.23 | +27.99% |
| June, 2026 | $18.06 | $17.32 | $24.14 | +2.70% |
| July, 2026 | $23.19 | $17.64 | $23.39 | +31.85% |
| August, 2026 | $21.38 | $20.24 | $24.24 | +21.57% |
| September, 2026 | $21.20 | $20.31 | $23.25 | +20.53% |
| October, 2026 | $19.57 | $18.81 | $21.39 | +11.27% |
| November, 2026 | $20.77 | $18.26 | $21.46 | +18.10% |
| December, 2026 | $19.96 | $18.81 | $21.11 | +13.48% |
Entrada Therapeutics Inc Stock (TRDA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Entrada Therapeutics Inc (TRDA) is $25.17, with a high forecast of $35.30 and a low forecast of $15.05. This indicates an +43.11% increase from the last price of $17.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $20.40 | $16.73 | $20.89 | +15.95% |
| February, 2027 | $21.57 | $18.26 | $26.91 | +22.61% |
| March, 2027 | $19.88 | $16.85 | $24.19 | +13.05% |
| April, 2027 | $17.89 | $16.41 | $20.84 | +1.68% |
| May, 2027 | $15.87 | $15.05 | $18.62 | -9.79% |
| June, 2027 | $19.58 | $15.51 | $19.80 | +11.34% |
| July, 2027 | $22.25 | $16.83 | $24.64 | +26.47% |
| August, 2027 | $23.19 | $19.70 | $23.39 | +31.82% |
| September, 2027 | $23.19 | $20.72 | $25.51 | +31.86% |
| October, 2027 | $25.80 | $22.20 | $26.34 | +46.65% |
| November, 2027 | $29.70 | $24.22 | $30.00 | +68.83% |
| December, 2027 | $28.89 | $27.90 | $35.30 | +64.27% |
Entrada Therapeutics Inc Stock (TRDA) Price Forecast for 2028
In 2028, Entrada Therapeutics Inc (TRDA) is projected to reach an average price of $26.84, with a high projection of $32.81 and a low estimate of $20.88. This indicates an +52.59% rise from the last price of $17.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $30.24 | $23.52 | $32.81 | +71.90% |
| February, 2028 | $25.55 | $23.34 | $32.64 | +45.24% |
| March, 2028 | $25.89 | $22.57 | $27.04 | +47.16% |
| April, 2028 | $24.38 | $20.88 | $28.53 | +38.58% |
| May, 2028 | $26.30 | $21.17 | $29.02 | +49.54% |
| June, 2028 | $23.66 | $23.14 | $30.32 | +34.48% |
| July, 2028 | $23.85 | $22.75 | $26.08 | +35.57% |
| August, 2028 | $27.00 | $22.74 | $29.35 | +53.52% |
| September, 2028 | $29.47 | $23.54 | $30.85 | +67.51% |
| October, 2028 | $28.96 | $26.05 | $29.98 | +64.62% |
| November, 2028 | $26.97 | $25.67 | $30.28 | +53.35% |
| December, 2028 | $27.72 | $25.84 | $29.58 | +57.56% |
Entrada Therapeutics Inc Stock (TRDA) Price Forecast for 2029
The 2029 price forecast for Entrada Therapeutics Inc Stock (TRDA) is $26.46 on average, with a high prediction of $31.63 and a low estimate of $21.30. This represents an +50.45% increase from the previous price of $17.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $29.69 | $25.59 | $30.02 | +68.80% |
| February, 2029 | $26.15 | $23.90 | $30.69 | +48.69% |
| March, 2029 | $29.86 | $25.70 | $30.06 | +69.73% |
| April, 2029 | $28.12 | $26.94 | $30.92 | +59.85% |
| May, 2029 | $28.02 | $27.12 | $30.00 | +59.32% |
| June, 2029 | $26.47 | $25.71 | $28.23 | +50.46% |
| July, 2029 | $27.74 | $25.17 | $28.40 | +57.69% |
| August, 2029 | $26.95 | $25.81 | $28.09 | +53.22% |
| September, 2029 | $25.06 | $21.35 | $25.50 | +42.46% |
| October, 2029 | $26.38 | $22.94 | $31.63 | +50.00% |
| November, 2029 | $24.71 | $21.65 | $28.96 | +40.46% |
| December, 2029 | $22.78 | $21.30 | $25.68 | +29.50% |
Entrada Therapeutics Inc Stock (TRDA) Price Forecast for 2030
Entrada Therapeutics Inc Stock (TRDA) is expected to reach an average price of $30.38 in 2030, with a high forecast of $40.76 and a low forecast of $20.01. This signifies an +72.74% surge from the last price of $17.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $20.94 | $20.01 | $23.53 | +19.07% |
| February, 2030 | $24.64 | $20.53 | $24.86 | +40.06% |
| March, 2030 | $27.37 | $21.91 | $29.75 | +55.60% |
| April, 2030 | $28.38 | $24.88 | $28.58 | +61.35% |
| May, 2030 | $28.48 | $25.95 | $30.77 | +61.90% |
| June, 2030 | $31.15 | $27.54 | $31.69 | +77.09% |
| July, 2030 | $38.98 | $29.61 | $39.82 | +121.58% |
| August, 2030 | $34.41 | $33.42 | $40.76 | +95.61% |
| September, 2030 | $35.82 | $29.05 | $38.39 | +103.64% |
| October, 2030 | $30.73 | $29.00 | $38.26 | +74.67% |
| November, 2030 | $31.63 | $28.29 | $31.63 | +79.80% |
| December, 2030 | $30.19 | $26.65 | $34.29 | +71.63% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):